Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-28

Clinical Trial Update: Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 safety and tolerability study of Cycloset for type 2 diabetes has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSET (BROMOCRIPTINE MESYLATE)

Snippet

Sponsor: VeroScience | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2011-10-28